| |
| |
|
| Insider
Information: |
Schimmel Paul |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
1,717,702 |
|
|
Indirect Shares
|
1,312,785 |
|
|
| Direct
Value |
$98,588,229 |
|
|
|
Indirect Value
|
$46,439,304 |
|
|
| Total
Shares |
3,030,487 |
|
|
| Total
Value |
$145,027,533 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alnylam Pharmaceuticals Inc |
ALNY |
Director |
2018-03-13 |
0 |
2018-03-13 |
306,996 |
Premium* |
|
|
Repligen Corp |
RGEN |
Director |
2007-06-14 |
665,106 |
2005-11-07 |
0 |
Premium* |
|
|
Avicena Group, Inc. |
AVCE |
Director |
2006-12-28 |
1,020,242 |
2005-11-23 |
0 |
Premium* |
|
|
aTyr Pharma Inc |
LIFE |
Director |
2023-05-10 |
8,890 |
2023-05-10 |
992,166 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
Director |
2017-04-19 |
23,464 |
2017-04-19 |
13,623 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
84 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-12-20 |
4 |
B |
$2.27 |
$34,110 |
I/I |
15,000 |
711,814 |
2.1 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2018-08-31 |
4 |
B |
$0.72 |
$15,752 |
I/I |
22,000 |
714,328 |
2.1 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2016-12-21 |
4 |
B |
$2.28 |
$22,818 |
I/I |
10,000 |
721,814 |
2.1 |
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2018-09-04 |
4 |
B |
$0.76 |
$15,709 |
I/I |
20,749 |
735,077 |
2.1 |
- |
|
| AVCE |
Avicena Group, Inc. |
officerTitle |
– • – |
2005-11-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
837,143 |
|
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2018-11-26 |
4 |
B |
$0.54 |
$79,796 |
I/I |
147,225 |
882,302 |
2.1 |
- |
|
| AVCE |
Avicena Group, Inc. |
Director |
– • – |
2006-12-28 |
5 |
GD |
$0.00 |
$0 |
D/D |
185,000 |
1,020,242 |
0 |
- |
|
| AVCE |
Avicena Group, Inc. |
Director |
– • – |
2005-11-23 |
4 |
A |
$0.00 |
$0 |
D/D |
33,242 |
1,205,242 |
|
- |
|
| LIFE |
aTyr Pharma Inc |
Director |
– • – |
2019-04-12 |
4 |
A |
$0.54 |
$1,000,000 |
I/I |
1,848,428 |
2,570,242 |
0 |
- |
|
84 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
